Alicia L. Graham

Researcher

University of Arkansas for Medical Sciences

unknown

3 h-index 4 pubs 44 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Alicia L. Graham investigates the use of live attenuated viruses as cancer immunotherapies. Her work includes repurposing the MMR vaccine for cancer immunotherapy and exploring the potential of the oncolytic Jurona virus in combination with immune checkpoint blockade for hepatocellular carcinoma treatment. Graham has published research on the in vivo safety and immunoactivity of oncolytic Jurona virus, including comprehensive proteogenomic analyses. Her scholarly output includes four publications with 44 citations, and she holds an h-index of 3. Graham collaborates with Steven R. Post, Martin J. Cannon, Mulu Z. Tesfay, and Camila Simões, all from the University of Arkansas for Medical Sciences, with whom she has co-authored three publications.

Metrics

  • h-index: 3
  • Publications: 4
  • Citations: 44

Selected Publications

  • Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade (2024) DOI
  • Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy (2022) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics